
Vidya Sagar Maddela
Contributor at World Pharmaceutical Frontiers
Contributor at Future Banking Magazine
Articles
-
1 day ago |
ingredients-insight.com | Vidya Sagar Maddela
Compound Foods, a US-based food tech startup creating sustainable ingredients, has unveiled its innovative beanless coffee and cocoa ingredients platform. Designed to mitigate risks in global supply chains, the platform offers brands functional and flavourful alternatives to traditional coffee and cocoa. Also, the platform addresses the increasing instability in production due to supply shortages, climate pressures, and volatile prices.
-
1 day ago |
practical-patient-care.com | Vidya Sagar Maddela
Force Therapeutics has announced a strategic collaboration with ECU Health, a not-for-profit hospital system, to enhance patient engagement through digital care solutions. The partnership aims to standardise care pathways, automate the collection of patient-reported outcome measurements (PROMs), and optimise remote care. Also, it will reduce readmissions and support compliance with the Centres for Medicare & Medicaid Services (CMS).
-
1 day ago |
worldpharmaceuticals.net | Vidya Sagar Maddela
US-based biotechnology company Tempus has announced a strategic collaboration with AstraZeneca and Pathos to develop a multimodal foundation model in oncology. The partnership aims to leverage Tempus’ AI capabilities and oncology data to generate biological and clinical insights, discover novel drug targets, and develop cancer therapeutics. The foundation model will be shared among all three parties to enhance patient care.
-
1 day ago |
worldpharmaceuticals.net | Vidya Sagar Maddela
US-based biotechnology company Repertoire Immune Medicines has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche Group. The collaboration aims to develop T cell-targeted therapies for an autoimmune disease. Under the partnership, Repertoire will use its DECODE platform to identify new targets. Genentech will be responsible for preclinical and clinical development, and global commercialisation of the T cell-targeted therapies.
-
1 day ago |
practical-patient-care.com | Vidya Sagar Maddela
Physical Rehabilitation Network (PRN) has announced a partnership with healthcare technology company Limber Health to enhance clinical innovation through hybrid care. The collaboration aims to improve patient outcomes by integrating digital tools into PRN’s rehabilitation services. Limber Health will provide solutions like Remote Therapeutic Monitoring (RTM) and home exercise programmes to extend care beyond the clinic.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →